Sign inTry free
Edgewise Therapeutics (EWTX) logo

Edgewise Therapeutics (EWTX) insider trading in the last 6 months

6 insiders sold $2.1M. No buys.

Filings: 20, in the last 6 months
Quality Score: 10, Average

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 20 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellMichael Nofi$202KChief Financial Officerat $45.43 on today, filed today
SellKevin Koch$383KPresident and CEOat $43.64 on Aug 12, filed Aug 14
SellKevin Koch$361KPresident and CEOat $43.66 on Aug 12, filed Aug 14

From SEC Form 4s, the newest filed Nov 10, 2026 · Insiders have 2 business days to file a trade

17 more filings on EWTX in the last 6 months, for Pro members. See them free →

Pro members see every filing on EWTX with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Edgewise Therapeutics

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about EWTX's insider trades

As of Nov 10, 2026: Edgewise Therapeutics (EWTX) has 20 insider filings on record in the last 6 months, the newest filed Nov 10, 2026. Its Quality Score is 10 (Average). Scores as of 10:56 PM ET, 15 minutes behind.

Are EWTX insiders buying or selling?

6 insiders sold $2.1M across 20 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Michael Nofi, Chief Financial Officer, sold $202K on Nov 10, 2026.

Who are EWTX's biggest insider sellers?

By the dollars of their sales in the last 6 months: Kevin Koch (President and CEO), 3 sales; Joanne M. Donovan (CMO), 5 sales; Alan J. Russell (Chief Scientific Officer), 3 sales. 6 insiders sold in all.

When did an EWTX insider last buy?

No EWTX insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Michael Nofi on Nov 10, 2026.

Edgewise Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Every insider trade, with its stock's score.

Real-time prices, every Form 4 on every stock with its Quality Score, sorting, filters, and optional alerts when the people you follow file.

See the last 30 days of insider trades

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Shares insiders bought or sold themselves, as filed on Form 4. Grants, option exercises, shares withheld for tax, and 10b5-1 plan sales are left out.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

May we record how this site is used and measure our ads? Privacy policy

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.